313549-93-8

Basic information

• Product Name: 3-(4-cyanophenoxy)benzoic acid
• Synonyms: 3-(4-cyanophenoxy)benzoic acid
• CAS NO: 313549-93-8
• Molecular Formula: C₁₄H₉NO₃
• Molecular Weight: 239.22616
• Mol File: 313549-93-8.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-(4-cyanophenoxy)benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-cyanophenoxy)benzoic acid(313549-93-8)
• EPA Substance Registry System: 3-(4-cyanophenoxy)benzoic acid(313549-93-8)

Safety Data

• Hazardous Substances Data: 313549-93-8(Hazardous Substances Data)

Upstream product

• 934690-54-7 Methyl 3-(4-cyanophenoxy)benzoate 
• 618-89-3 methyl 3-bromobenzoate 
• 126747-14-6 4-cyanophenylboronic acid 

Relevant articles and documents

HETEROCYCLIC INHIBITORS OF PCSK9

This application relates to chemical compounds which may act as inhibitors of, or which may otherwise modulate the activity of, PCSK9, or a pharmaceutically acceptable salt, solvate, prodrug or polymorph thereof, and to compositions and formulations comprising such compounds, and methods of using and making such compounds. Compounds include compounds of Formula (I): (I) wherein A, D and Q are described herein.

BENZAMIDE COMPOUND

[Problem] A compound which is useful as a GK activator is provided. [Means for Solution] The present inventors have conducted studies on compounds having a GK activating action, which are promising as active ingredients of pharmaceutical compositions for

Pharmaceutically active benzoquinazoline compounds

Compounds of formula (I) or salts thereof, wherein the dotted line represents a single or double bond, R1is alkyl or amino optionally substituted by alkyl, alkanoyl or benzyl group; R2, R3, R4and R5are the same or different and each is selected from hydrogen, phenyl, halo, nitro, a group S(O)nR8wherein n is the integer 0, 1 or 2 and R8is halo or alkyl or a group NR9R10wherein R9and R10are both hydrogen, a group NR11R12wherein R11and R12are the same or different and each is hydrogen or alkyl, a group OR13wherein R13is hydrogen or C1-4alkyl optionally substituted by halo; a C1-4aliphatic group optionally substituted by a group OR14or NR14R15wherein R14and R15are the same or different and each is hydrogen or alkyl; or two of R2to R5are linked together to form a benzo group, or one of R2to R5is a group -X-Y-R16wherein X is CH2, NR17, CO or S(O)m, and Y is CH2, NR17, O, or S(O)m, or -X-Y- is a group -O-, -NR17-, -CH=CH- or -N=N-, are disclosed as pharmacological agents useful in the treatment of tumours. Pharmaceutical compositions and methods for the preparation of compounds of formula (I) are also described.